New Wolfson laboratory to process 200,000+ Covid-19 samples
The Wolfson Institute has received a £3.6 million grant to establish a laboratory for UK Covid-19 testing. Dr Belinda Nedjai is leading the set-up of the Molecular Epidemiology Laboratory, including recruitment of 20 new staff and coordination of the infrastructure to process at least 200,000 COVID-19 samples from the general population in London between December 2020 and March 2021. As part of the Med-City Testing Alliance, Queen Mary, along with UCL, King’s, and Imperial, will offer a combined capacity of at least 20,500 more RT-PCR tests a day. The Wolfson is recruiting laboratory scientists, molecular biologists, and technicians (Contact Dr Nedjai).
Dr Nedjai told us: “I saw too many people around me suffering with this terrible disease, and so responding to the government call to increase UK testing capacity seemed the best way to contribute towards the national effort. The Wolfson has world-leading medical statisticians, epidemiologists, and molecular biologists, with a wealth of experience and a proven research track record to help to better understand Covid-19 and monitor incidence rates in London. Helping our community is at the heart of our engagement, and we hope that this alliance will prompt further innovation in COVID-19 disease management, and allow us to explore other innovative approaches and techniques for testing in the future.”
Med-City is part-funded by the Mayor of London. Other partners supporting the Alliance’s efforts include: the Greater London Authority, NHS, Public Health England, the multi-agency Regional Strategic Testing Group, and the Department for Health and Social Care.